Head-to-Head

Immunovant, Inc. Common Stock vs. Repligen Corp

IMVT

Immunovant, Inc. Common Stock

$29.04 +2.22%

VS RGEN

Repligen Corp

$178.27 +3.08%

Immunovant, Inc. Common Stock and Repligen Corp are evenly matched on the factors we track — the better pick depends on what you're optimizing for.

Size & Scale

IMVTRGEN
Market Cap $5.87 billion $10.98 billion

RGEN leads on 1 of 1 size & scale factors.

Risk & Sentiment

IMVTRGEN
Short Interest 0.15% 7.13%

IMVT leads on 1 of 1 risk & sentiment factors.

Dig deeper: IMVT overview, IMVT financials, RGEN overview, RGEN financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.